Logo image of MRD.CA

MELCOR DEVELOPMENTS LTD (MRD.CA) Stock Fundamental Analysis

Canada - Toronto Stock Exchange - TSX:MRD - CA5854671032 - Common Stock

15.43 CAD
-0.07 (-0.45%)
Last: 12/5/2025, 7:00:00 PM
Fundamental Rating

6

Overall MRD gets a fundamental rating of 6 out of 10. We evaluated MRD against 33 industry peers in the Real Estate Management & Development industry. MRD has an excellent financial health rating, but there are some minor concerns on its profitability. MRD scores decently on growth, while it is valued quite cheap. This could make an interesting combination. This makes MRD very considerable for value investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year MRD was profitable.
MRD had a positive operating cash flow in the past year.
MRD had positive earnings in each of the past 5 years.
Each year in the past 5 years MRD had a positive operating cash flow.
MRD.CA Yearly Net Income VS EBIT VS OCF VS FCFMRD.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

With a decent Return On Assets value of 2.85%, MRD is doing good in the industry, outperforming 66.67% of the companies in the same industry.
The Return On Equity of MRD (4.72%) is comparable to the rest of the industry.
MRD's Return On Invested Capital of 5.50% is fine compared to the rest of the industry. MRD outperforms 78.79% of its industry peers.
The Average Return On Invested Capital over the past 3 years for MRD is significantly below the industry average of 10.35%.
The 3 year average ROIC (3.82%) for MRD is below the current ROIC(5.50%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.85%
ROE 4.72%
ROIC 5.5%
ROA(3y)2.91%
ROA(5y)2.39%
ROE(3y)5.16%
ROE(5y)4.32%
ROIC(3y)3.82%
ROIC(5y)3.63%
MRD.CA Yearly ROA, ROE, ROICMRD.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6

1.3 Margins

MRD's Profit Margin of 14.91% is fine compared to the rest of the industry. MRD outperforms 60.61% of its industry peers.
MRD's Profit Margin has declined in the last couple of years.
With a decent Operating Margin value of 38.68%, MRD is doing good in the industry, outperforming 69.70% of the companies in the same industry.
In the last couple of years the Operating Margin of MRD has grown nicely.
The Gross Margin of MRD (47.83%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of MRD has remained more or less at the same level.
Industry RankSector Rank
OM 38.68%
PM (TTM) 14.91%
GM 47.83%
OM growth 3Y0.63%
OM growth 5Y5.89%
PM growth 3Y-18.68%
PM growth 5Y-11.95%
GM growth 3Y0.48%
GM growth 5Y-0.66%
MRD.CA Yearly Profit, Operating, Gross MarginsMRD.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

7

2. Health

2.1 Basic Checks

MRD has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, MRD has less shares outstanding
MRD has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, MRD has an improved debt to assets ratio.
MRD.CA Yearly Shares OutstandingMRD.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
MRD.CA Yearly Total Debt VS Total AssetsMRD.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

Based on the Altman-Z score of 1.64, we must say that MRD is in the distress zone and has some risk of bankruptcy.
With a decent Altman-Z score value of 1.64, MRD is doing good in the industry, outperforming 63.64% of the companies in the same industry.
The Debt to FCF ratio of MRD is 5.63, which is a neutral value as it means it would take MRD, 5.63 years of fcf income to pay off all of its debts.
MRD's Debt to FCF ratio of 5.63 is amongst the best of the industry. MRD outperforms 87.88% of its industry peers.
MRD has a Debt/Equity ratio of 0.48. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of MRD (0.48) is better than 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF 5.63
Altman-Z 1.64
ROIC/WACC0.8
WACC6.9%
MRD.CA Yearly LT Debt VS Equity VS FCFMRD.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 3.44 indicates that MRD has no problem at all paying its short term obligations.
With an excellent Current ratio value of 3.44, MRD belongs to the best of the industry, outperforming 84.85% of the companies in the same industry.
MRD has a Quick Ratio of 3.44. This indicates that MRD is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 3.44, MRD belongs to the best of the industry, outperforming 84.85% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.44
Quick Ratio 3.44
MRD.CA Yearly Current Assets VS Current LiabilitesMRD.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

4

3. Growth

3.1 Past

MRD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 414.41%, which is quite impressive.
Measured over the past years, MRD shows a decrease in Earnings Per Share. The EPS has been decreasing by -0.67% on average per year.
Looking at the last year, MRD shows a very strong growth in Revenue. The Revenue has grown by 29.55%.
The Revenue has been growing by 10.94% on average over the past years. This is quite good.
EPS 1Y (TTM)414.41%
EPS 3Y-13.69%
EPS 5Y-0.67%
EPS Q2Q%140.67%
Revenue 1Y (TTM)29.55%
Revenue growth 3Y3.46%
Revenue growth 5Y10.94%
Sales Q2Q%21.9%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-5.24%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-3.26%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MRD.CA Yearly Revenue VS EstimatesMRD.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
MRD.CA Yearly EPS VS EstimatesMRD.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0.5 1 1.5 2 2.5

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 8.12, which indicates a very decent valuation of MRD.
MRD's Price/Earnings ratio is a bit cheaper when compared to the industry. MRD is cheaper than 72.73% of the companies in the same industry.
MRD is valuated cheaply when we compare the Price/Earnings ratio to 26.46, which is the current average of the S&P500 Index.
MRD is valuated cheaply with a Price/Forward Earnings ratio of 7.68.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MRD indicates a rather cheap valuation: MRD is cheaper than 100.00% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of MRD to the average of the S&P500 Index (36.10), we can say MRD is valued rather cheaply.
Industry RankSector Rank
PE 8.12
Fwd PE 7.68
MRD.CA Price Earnings VS Forward Price EarningsMRD.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MRD indicates a rather cheap valuation: MRD is cheaper than 93.94% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of MRD indicates a rather cheap valuation: MRD is cheaper than 96.97% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 4.4
EV/EBITDA 6.39
MRD.CA Per share dataMRD.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The decent profitability rating of MRD may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.35%, MRD has a reasonable but not impressive dividend return.
MRD's Dividend Yield is a higher than the industry average which is at 3.42.
MRD's Dividend Yield is a higher than the S&P500 average which is at 2.32.
Industry RankSector Rank
Dividend Yield 3.35%

5.2 History

The dividend of MRD decreases each year by -2.57%.
MRD has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-2.57%
Div Incr Years0
Div Non Decr Years0
MRD.CA Yearly Dividends per shareMRD.CA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

MRD pays out 23.67% of its income as dividend. This is a sustainable payout ratio.
The Dividend Rate of MRD has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP23.67%
EPS Next 2YN/A
EPS Next 3YN/A
MRD.CA Yearly Income VS Free CF VS DividendMRD.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M
MRD.CA Dividend Payout.MRD.CA Dividend Payout, showing the Payout Ratio.MRD.CA Dividend Payout.PayoutRetained Earnings

MELCOR DEVELOPMENTS LTD

TSX:MRD (12/5/2025, 7:00:00 PM)

15.43

-0.07 (-0.45%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)11-06 2025-11-06
Earnings (Next)03-11 2026-03-11
Inst Owners8.78%
Inst Owner ChangeN/A
Ins Owners14.12%
Ins Owner ChangeN/A
Market Cap463.67M
Revenue(TTM)393.96M
Net Income(TTM)58.75M
Analysts45.71
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.35%
Yearly Dividend0.44
Dividend Growth(5Y)-2.57%
DP23.67%
Div Incr Years0
Div Non Decr Years0
Ex-Date12-15 2025-12-15 (0.13)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 8.12
Fwd PE 7.68
P/S 1.18
P/FCF 4.4
P/OCF 4.02
P/B 0.37
P/tB 0.37
EV/EBITDA 6.39
EPS(TTM)1.9
EY12.31%
EPS(NY)2.01
Fwd EY13.03%
FCF(TTM)3.51
FCFY22.72%
OCF(TTM)3.84
OCFY24.87%
SpS13.1
BVpS41.42
TBVpS41.42
PEG (NY)N/A
PEG (5Y)N/A
Graham Number42.08
Profitability
Industry RankSector Rank
ROA 2.85%
ROE 4.72%
ROCE 7.63%
ROIC 5.5%
ROICexc 5.73%
ROICexgc 5.9%
OM 38.68%
PM (TTM) 14.91%
GM 47.83%
FCFM 26.77%
ROA(3y)2.91%
ROA(5y)2.39%
ROE(3y)5.16%
ROE(5y)4.32%
ROIC(3y)3.82%
ROIC(5y)3.63%
ROICexc(3y)3.93%
ROICexc(5y)3.72%
ROICexgc(3y)4.06%
ROICexgc(5y)3.84%
ROCE(3y)5.31%
ROCE(5y)5.03%
ROICexgc growth 3Y4.23%
ROICexgc growth 5Y17.72%
ROICexc growth 3Y4.16%
ROICexc growth 5Y17.7%
OM growth 3Y0.63%
OM growth 5Y5.89%
PM growth 3Y-18.68%
PM growth 5Y-11.95%
GM growth 3Y0.48%
GM growth 5Y-0.66%
F-Score9
Asset Turnover0.19
Health
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF 5.63
Debt/EBITDA 3.87
Cap/Depr 841.25%
Cap/Sales 2.54%
Interest Coverage 250
Cash Conversion 75.16%
Profit Quality 179.48%
Current Ratio 3.44
Quick Ratio 3.44
Altman-Z 1.64
F-Score9
WACC6.9%
ROIC/WACC0.8
Cap/Depr(3y)1460.36%
Cap/Depr(5y)1587.21%
Cap/Sales(3y)6.3%
Cap/Sales(5y)7.47%
Profit Quality(3y)95.67%
Profit Quality(5y)124.25%
High Growth Momentum
Growth
EPS 1Y (TTM)414.41%
EPS 3Y-13.69%
EPS 5Y-0.67%
EPS Q2Q%140.67%
EPS Next Y-5.24%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)29.55%
Revenue growth 3Y3.46%
Revenue growth 5Y10.94%
Sales Q2Q%21.9%
Revenue Next Year-3.26%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y40.36%
EBIT growth 3Y4.12%
EBIT growth 5Y17.48%
EBIT Next Year-3.66%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y265.25%
FCF growth 3Y18.66%
FCF growth 5Y52.08%
OCF growth 1Y122.64%
OCF growth 3Y10.64%
OCF growth 5Y25.86%

MELCOR DEVELOPMENTS LTD / MRD.CA FAQ

What is the ChartMill fundamental rating of MELCOR DEVELOPMENTS LTD (MRD.CA) stock?

ChartMill assigns a fundamental rating of 6 / 10 to MRD.CA.


What is the valuation status of MELCOR DEVELOPMENTS LTD (MRD.CA) stock?

ChartMill assigns a valuation rating of 7 / 10 to MELCOR DEVELOPMENTS LTD (MRD.CA). This can be considered as Undervalued.


What is the profitability of MRD stock?

MELCOR DEVELOPMENTS LTD (MRD.CA) has a profitability rating of 6 / 10.


What are the PE and PB ratios of MELCOR DEVELOPMENTS LTD (MRD.CA) stock?

The Price/Earnings (PE) ratio for MELCOR DEVELOPMENTS LTD (MRD.CA) is 8.12 and the Price/Book (PB) ratio is 0.37.


What is the expected EPS growth for MELCOR DEVELOPMENTS LTD (MRD.CA) stock?

The Earnings per Share (EPS) of MELCOR DEVELOPMENTS LTD (MRD.CA) is expected to decline by -5.24% in the next year.